Skip to content

Surpass Streamline M003SFD030250Recalls & reported problems

Stryker Corporation · Flow Diverter · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07613252648765), received between Feb 4, 2019 and Feb 4, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Premature Separation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Premature Separation1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 4, 2019Premature Separation; Premature Separation

    IT WAS REPORTED THAT DURING PROCEDURE FOR STENTING AN ANEURYSM LOCATED IN THE LEFT INTERNAL CAROTID ARTERY (ICA) IN THE PETROUS SEGMENT, THE STENT (SUBJECT DEVICE) BECAME LOCKED INTO THE OUTER DELIVERY CATHETER AND PARTIALLY DEPLOYED. THUS, THE FORWARD PRESSURE STRETCHED THE DISTAL PART OF THE DELIVERY CATHETER. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8303080 ↗

Other Intracranial aneurysm flow diverter devices

All Intracranial aneurysm flow diverter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page